Avoiding risks of thrombosis and bleeding in major surgery (ARTS)
Description of the granted funding
Abdominal and pelvic surgery incurs risks of clots in the legs or lungs known as venous thromboembolism (VTE) and major bleeding. Pharmacological prophylaxis decreases the risk of VTE, but increases the risk of bleeding. The magnitude of these risks remains uncertain, resulting in varying clinical practice and guidelines. To determine its effect on symptomatic VTE and major bleeding, we plan a randomized control trial (RCT) comparing a direct oral anticoagulant (DOAC) to placebo in 5,300 patients undergoing abdominal or pelvic surgery. We will also conduct a number of blood tests that may help to predict VTE and bleeding in individual patients. Our RCT may show a clear net benefit in favor of DOACs or a clear net benefit to not using prophylaxis. Alternatively, it may show a close balance so that individual risk prediction and patients' feelings about VTE and bleeding will determine the best course of action. Any of these results will show us how to improve patient care.
Show moreStarting year
2021
End year
2025
Granted funding
Other information
Funding decision number
340957
Research fields
Kliiniset lääketieteet
Themes
Nuori tutkijasukupolvi 2020
Identified topics
intensive care, anesthesiology, radiology